These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Doing battle with HCV. Fimmel CJ Am J Gastroenterol; 2000 Mar; 95(3):582-3. PubMed ID: 10710043 [No Abstract] [Full Text] [Related]
5. Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Damonte EB; Coto CE Adv Virus Res; 2002; 58():125-55. PubMed ID: 12205778 [No Abstract] [Full Text] [Related]
6. Marketing scam spoils hep C treatment. Proj Inf Perspect; 1998 Dec; (26):6. PubMed ID: 11366498 [TBL] [Abstract][Full Text] [Related]
7. Ribavirin approved with a big fat price. Falkenberg J Notes Undergr; 1998; (No 37):10-1. PubMed ID: 11365818 [TBL] [Abstract][Full Text] [Related]
8. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. de la Torre JC Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Najafzadeh M; Andersson K; Shrank WH; Krumme AA; Matlin OS; Brennan T; Avorn J; Choudhry NK Ann Intern Med; 2015 Mar; 162(6):407-19. PubMed ID: 25775313 [TBL] [Abstract][Full Text] [Related]
10. Progress in the experimental therapy of severe arenaviral infections. Gowen BB; Bray M Future Microbiol; 2011 Dec; 6(12):1429-41. PubMed ID: 22122440 [TBL] [Abstract][Full Text] [Related]
11. [New drugs for hepatitis C]. Färkkilä M Duodecim; 2014; 130(18):1813-22. PubMed ID: 25558623 [TBL] [Abstract][Full Text] [Related]
12. FDA approves new combination treatment for hepatitis C. Food and Drug Administration. Baker R BETA; 1998 Jul; ():10. PubMed ID: 11365553 [TBL] [Abstract][Full Text] [Related]
13. Arenavirus and West Nile virus in solid organ transplantation. Singh N; Levi ME; Am J Transplant; 2013 Mar; 13 Suppl 4():361-71. PubMed ID: 23465029 [No Abstract] [Full Text] [Related]
14. Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration. Chan K; Lai MN; Groessl EJ; Hanchate AD; Wong JB; Clark JA; Asch SM; Gifford AL; Ho SB Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1503-10. PubMed ID: 23707354 [TBL] [Abstract][Full Text] [Related]
15. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ]. Einecke D MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054 [No Abstract] [Full Text] [Related]
16. [Evidence-based therapeutic drug monitoring for ribavirine]. Solas C; Paré M; Quaranta S; Stanke-Labesque F; Therapie; 2011; 66(3):221-30. PubMed ID: 21819806 [TBL] [Abstract][Full Text] [Related]
17. Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia. Poordad F; Theodore D; Sullivan J; Grotzinger K J Med Econ; 2011; 14(2):194-206. PubMed ID: 21348807 [TBL] [Abstract][Full Text] [Related]
18. Unknown disease in South Africa identified as arenavirus infection. Zeller H; Leitmeyer K; Santos CV; Coulombier D Euro Surveill; 2008 Oct; 13(42):. PubMed ID: 18926114 [TBL] [Abstract][Full Text] [Related]
19. Management of hepatitis C in Rhode Island: opportunities for improvement within and beyond the department of corrections. Berzin T; Allen S; Taylor L; Rich J; Feller E Med Health R I; 2002 Nov; 85(11):341-4. PubMed ID: 12462866 [No Abstract] [Full Text] [Related]
20. Pathogenesis of arenavirus hemorrhagic fevers. Moraz ML; Kunz S Expert Rev Anti Infect Ther; 2011 Jan; 9(1):49-59. PubMed ID: 21171877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]